Antihyperlipidemics Flashcards

1
Q

HMG CoA reductase inhibitors

A

atorvastatin

rosuvastatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

decrease liver cholesterol
increase LDL receptors
decrease plasma LDL
decrease VLDL synthesis: decrease tags

A

HMG CoA inhibitors “statins”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

myalgia
myopathy
rhabdomyolysis
hepatotoxicity

A

SE of HMG CoA inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drug interactions with HMG CoA inhibitors

A

Gemfibrozil
cytochrome p450 inhibitors enhance toxicity of statin
avoid in chronic alcohol drinkers and hepatitis pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what enzyme is decreased?

that decreases ATP and leads to myocyte damage

A

CoQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

statin contraindications

A

pregnant and lactating women
kids under 8
because the need cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

increase bile acid synthesis

A

resin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bile Acid sequestrants

A

cholestyramine

colestipol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
decrease recirculation of bile salts
increase synthesis of new bile salts
decrease liver cholesterol
increase LDL receptors
decrease blood LDL
A

Bile acid sequestrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

decrease blood cholesterol by 50-65%

A

Statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

decrease cholesterol by 20%

A

bile acid sequestrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

increase VLDL and tags
increase cholesterol in gall bladder = gall stones
constipation
Malabsorption of lipid soluble vitamins (A,D,E,K & folic acid)

A

bile acid sequestrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drug interaction with bile acid sequestrants

A

orally administered drugs (warfarin, thiazides, digoxin, etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hypertriglyceridemia

A

Contraindication of bile acid sequestrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
inhibits VLDL synthesis 
decreases plasma VLDL 
decreased plasma LDL (20-30%)
increase plasma HDL (30-40%)
decreases lipoprotein (a)
A

Niacin (B3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
flushing
pruritus 
burning pain
hepatotoxicity 
hyperglycemia
A

SE of niacin

can take aspirin to avoid increase in PG

17
Q

bind to PPARa and increase expression of lipoprotein lipases

A

Gemfibrozil

Fenofibrate (Fibrates)

18
Q
decrease VLDL (35%) and IDL
modest decrease LDL (10%)
increased HDL (10%)
A

gemfibrozil

fenofibrate

19
Q

used in hypertriglyceridemia

A

gemfibrozil

fenofibrate

20
Q

gallstones
myositis
myopathy

A

gemfibrozil

fenofibrate

21
Q

most effect at increasing HDL

A

niacin

22
Q

removing cholesterol from fatty streak in blood vessels and activates LCAT to esterize cholesterol (transferred to IDL and LDL by CETP)

A

increasing Apo A1 and A2

23
Q

directly blocks NPC1L1 receptor - increases LDL receptor - decreasing LDL in blood stream

A

Ezetimibe

24
Q

GIT distress

A

SE of Ezetimibe

25
Q

decreases cytosolic cholesterol and increases HDL 4-9%

A

Ezetimibe

26
Q

weight loss drug

A

orlistat

27
Q

inhibits pancreatic lipase - decreasing tags breakdown in intestine

A

orlistat

28
Q

oily stool
diarrhea
decrease absorption of lipid soluble vitamins

A

orlistat

29
Q

PCSK9 inhibitors

A

alirocumab

evolocumab

30
Q

decrease hepatic tags synthesis and increase tags clearance

A

omega 3 fatty acid

31
Q

indication: hypertriglyceridemia
Contraindications: fish allergy

A

omega 3 fatty acid

32
Q

are monoclonal antibody - bind to PCSK9 to inhibit LDL receptor degradation and increase LDL receptors; decreasing LDL (48-71%) and APO B (42-55%) in blood stream

A

PCSK 9 inhibitors

33
Q

Indications

1) heterozygous familial hypercholesterolemia
2) clinical atherosclerotic cardiovascular disease

A

PCSK 9 inhibitors

34
Q

ADR: allergy, nasopharyngitis, injection site reaction

A

PCSK 9 inhibitors